Imperial Valley News
Washington, DC - Forty states have enacted laws prohibiting the sale of electronic nicotine delivery systems (ENDS), including e-cigarettes, to minors, but 10 states and the District of Columbia still permit such sales, according to a report published by the Centers for Disease Control and Prevention in today’s Morbidity and Mortality Weekly Report (MMWR).
Imperial, California - Not every product lives up to its claims, and others sometimes exceed expectations. The January 2015 issue of ShopSmart, from Consumer Reports, spotlights the best of the best tested this year which includes more than 45 products in these seven categories: food and wine; cooking, food prep & storage; cleaning; home improvement; beauty, heath, and fitness; electronics; and cars.
President Obama Launches Competitions for New Manufacturing Innovation Hubs and American Apprenticeship Grants
Washington, DC - Today, at a meeting of the President’s Export Council (PEC), President Obama will announce nearly $400 million to help improve the competitiveness of American businesses and workers by spurring new manufacturing innovations and giving America workers additional opportunities to improve and expand their skill sets for middleclass jobs.
West Lafayette, Indiana - A new method that creates large-area patterns of three-dimensional nanoshapes from metal sheets represents a potential manufacturing system to inexpensively mass produce innovations such as "plasmonic metamaterials" for advanced technologies.
Washington, DC - Marketers who pitched homeopathic HCG drops as a quick and easy way to lose substantial weight have agreed to pay $1 million to settle Federal Trade Commission charges that their weight-loss claims were deceptive and not supported by scientific evidence. The defendants have stopped selling HCG Platinum drops, and under the settlement, Kevin Wright and his Utah-based companies, HCG Platinum, LLC and Right Way Nutrition, LLC, are banned from making similar weight-loss claims in the future.
Washington, DC - The U.S. Food and Drug Administration today approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II). This test is intended for use as an additional, more specific test for human serum or plasma specimens that have previously tested positive on an FDA-licensed HTLV-I/II blood donor screening test. The MP Diagnostics HTLV Blot 2.4 is a qualitative enzyme immunoassay test intended to confirm infection with HTLV and to differentiate between HTLV-I and HTLV-II.